Long-Term Arrangements for Supply of Measles-Containing Vaccines
UNICEF
Long-Term Arrangements for Supply of Measles-Containing Vaccines
Request for proposal
Reference:
RFP-DAN-2020-503220
Beneficiary countries or territories:
Multiple destinations (see the Countries or territories tab)
Published on:
17-Sep-2020
Deadline on:
12-Oct-2020 16:00 (GMT 2.00)
Description
For a complete set of solicitation documents, please refer to the attachments section of this tender notice.
Lilia Velinova-De Boever - lvelinova@unicef.org, Tel: +45 00000
Email address:
lvelinova@unicef.org
First name:
Lilia
Surname:
Velinova-De Boever
Telephone country code:
Denmark (+45)
Telephone number:
00000
This procurement opportunity integrates considerations for at least one sustainability indicator. However, it does not meet the requirements to be considered sustainable.
Human rights and labour issues
Social
The tender contains sustainability considerations related to human rights, fundamental principles and rights at work, occupational health and safety, fairly traded goods, targeted employment of people with disabilities, etc.
Supplier audits
Generic
The tender incorporates contract conditions/ KPIs that stipulate the verification of suppliers' environmental and social claims through “spot checks” and audit provisions.
51201604
-
Diphteria vaccine
51201606
-
Hemophilus influenzae vaccine
51201607
-
Hepatitis B virus vaccine
51201608
-
Influenza virus vaccine
51201609
-
Measles virus vaccine
51201610
-
Meningococcal vaccine
51201615
-
Pneumococcal vaccine
51201616
-
Poliovirus vaccine
51201617
-
Rabies vaccine
51201618
-
Rota virus vaccine
51201620
-
Smallpox vaccine
51201621
-
Tetanus vaccine
51201623
-
Typhoid vaccine
51201624
-
Varicella virus vaccine
51201625
-
Yellow fever vaccine
51201626
-
Hepatitis A virus vaccine
51201627
-
Haemophilus B vaccine
51201628
-
Measles and mumps and rubella virus vaccine
51201629
-
Diphtheria and tetanus toxoids absorbed
51201631
-
Diptheria and tetanus toxoids and acellular pertussis vaccine
51201632
-
Diptheria and tetanus and wholecell pertussis vaccine
51201633
-
Haemophilus influenzae b with diptheria and tetanus and acellular pertussis
51201634
-
Haemophilus influenzae B with diptheria and tetanus and wholecell pertussis conjugated vaccine
51201646
-
Measles and rubella virus vaccine
51201648
-
Rubella and mumps virus vaccine
51201652
-
COVID19 - Pfizer Biontech
51201653
-
COVID19 - Moderna
51201654
-
COVID19 - Sputnik V
51201655
-
COVID19 - AstraZeneca
51201656
-
COVID19 - Johnson & Johnson
51201657
-
Malaria vaccine
51201658
-
Cholera vaccine
51201659
-
COVID 19 - Unspecified
51201660
-
Ebola vaccine
Please note that a document containing the third and last set of questions by bidders, along with UNICEF's clarifications, has been uploaded under the Documents section of the tender notice.
Edited on:
08-Oct-2020 10:48
Edited by:
lvelinova@unicef.org
Please note that a document containing the second set of questions by bidders, along with UNICEF's clarifications, has been uploaded under the Documents section of the tender notice.
Edited on:
02-Oct-2020 11:25
Edited by:
lvelinova@unicef.org
Please note that a document containing the first set of questions by bidders, along with UNICEF's clarifications, has been uploaded under the Documents section of the tender notice.
Edited on:
24-Sep-2020 16:53
Edited by:
lvelinova@unicef.org